BURLINGTON, Mass. (AP) — Flexion Therapeutics Inc. (FLXN) on Wednesday reported a loss of $43.6 million in its third quarter.
The Burlington, Massachusetts-based company said it had a loss of $1.15 per share.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.24 per share.
The specialty pharmaceutical companies that specializes in pain relief posted revenue of $7 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $5.9 million.
Flexion Therapeutics shares have fallen 43 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $14.27, a fall of 40 percent in the last 12 months.